Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSemaglutide, the active peptide in Wegovy, causes side effects in most people who take it — particularly during the early weeks of treatment and after each dose increase. The most commonly reported are digestive: nausea, loose stools, constipation, and bloating are all well-documented in the clinical trials and in NHS guidance on semaglutide. They are real and, for some people, genuinely disruptive. They are also, for the majority, temporary. What this page covers is what the evidence actually says about those effects, which ones can be managed at home, and which ones are signals to call for help quickly — because that distinction genuinely matters.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide is a GLP-1 receptor agonist, it mimics a gut hormone that naturally rises after eating. One of its key mechanisms is slowing how quickly the stomach empties its contents into the small intestine. That's part of how it reduces hunger. But it's also the reason so many people feel queasy, particularly in the first few days after starting or increasing their dose.
The peptide acts on receptors in the gut wall and in areas of the brain involved in nausea. So the nausea isn't random, it's a direct consequence of the mechanism that makes the medicine work. Knowing that doesn't make it more pleasant, but it does explain why eating large meals or fatty foods tends to make things worse, and why smaller, plainer portions usually help.
Common side effects reported in trials and in the NHS semaglutide medicines page include: nausea, vomiting, diarrhoea, constipation, stomach pain, burping, indigestion, reflux, headache, dizziness, fatigue, and reactions at the injection site. They tend to cluster around the adjustment period. The titration schedule (starting at a low dose and stepping up gradually) exists specifically to reduce their severity. Most people find the effects are worst in the first day or two after a dose change, then fade.
Our prescribers talk through this adjustment period as a normal part of the initial consultation process, so you know what to expect before your first pen arrives.
Most of the gastrointestinal effects fall into the category of manageable, if unpleasant. Practical steps that many people find useful: eating slowly, stopping before you feel full, avoiding very fatty or rich foods in the first few weeks, staying well hydrated, and eating ginger-based foods or drinks for nausea. None of these are a cure, but they take the edge off for a lot of people.
Constipation (which tends to be more of an issue for some people than diarrhoea) often responds well to increased fluid intake and soluble fibre. Fatigue and mild headaches in the early weeks are also commonly reported and usually short-lived.
If you're unsure whether what you're experiencing falls within the expected range, the full semaglutide side effects guide covers the broader picture in more detail. There's also a useful breakdown of how long semaglutide side effects typically last if you're wondering whether your symptoms are running longer than expected.
One thing worth mentioning: some people do find the side effects noticeably harder in the mornings, particularly when taking the weekly injection the day before a busy day. A fair few people on Wegovy choose to inject on a Friday evening so the worst of it, if any, lands over a Saturday rather than a Tuesday morning before the school run.
This is the section that matters most. Some side effects are not manageable at home and need prompt medical attention. The clearest of these is severe, persistent stomach pain, particularly pain that spreads towards the back, with or without vomiting. This pattern can indicate acute pancreatitis, which the MHRA highlighted in a Drug Safety Update published in January 2026 as an infrequent but serious known risk with GLP-1 medicines. Do not wait to see if it passes. Contact your GP or call 111, or go to A&E if the pain is severe.
Other situations that need prompt attention include: signs of a gallbladder problem (sudden right-sided or upper stomach pain, fever, jaundice); signs of a serious allergic reaction (swelling of the face, lips or throat, difficulty breathing, severe rash); symptoms of severe dehydration from persistent vomiting or diarrhoea (dizziness when standing, very dark urine, no urination); and any significant changes in mood, low mood, or thoughts of self-harm.
For a closer look at what the evidence says about the more serious end of semaglutide's effects, the guide to more serious semaglutide side effects covers these in greater depth. You can also find a broader summary of Wegovy's reported side effects alongside how they're managed in clinical practice.
If you're unsure about any symptom you're experiencing, our aftercare team is available seven days a week, you won't be left to figure it out alone.
The injection route matters less than the dosing pattern. What tends to make the biggest difference to tolerability is how carefully the titration schedule is followed, moving to a higher dose before the body has had time to adjust is one of the most common reasons people experience intense side effects. The schedule exists for a reason, and the prescriber's judgement about when to move up a step is clinically significant, not administrative.
Injection technique can affect local reactions at the site, rotating between the abdomen, thigh and upper arm reduces the chance of skin changes developing in one spot. The Patient Information Leaflet that comes with your pen covers this precisely; for anything beyond basic technique questions, the FAQs are a reasonable starting point, though your prescriber should always be the final word on your individual plan.
People who are curious about the wider treatment picture, including how the side effects from semaglutide compare across different stages of treatment, or those exploring weight-loss treatment options more broadly, will find both pages cover those angles in more detail. The side effect of semaglutide overview is also worth reading alongside this one if you want a consolidated picture before speaking to a prescriber.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.